| Literature DB >> 22948820 |
Stefan Kernstock1, Erna Davydova, Magnus Jakobsson, Anders Moen, Solveig Pettersen, Gunhild M Mælandsmo, Wolfgang Egge-Jacobsen, Pål Ø Falnes.
Abstract
Valosin-containing protein (VCP, also called p97) is an essential and highly conserved adenosine triphosphate-dependent chaperone implicated in a wide range of cellular processes in eukaryotes, and mild VCP mutations can cause severe neurodegenerative disease. Here we show that mammalian VCP is trimethylated on Lys315 in a variety of cell lines and tissues, and that the previously uncharacterized protein METTL21D (denoted here as VCP lysine methyltransferase, VCP-KMT) is the responsible enzyme. VCP methylation was abolished in three human VCP-KMT knockout cell lines generated with zinc-finger nucleases. Interestingly, VCP-KMT was recently reported to promote tumour metastasis, and indeed, VCP-KMT-deficient cells displayed reduced growth rate, migration and invasive potential. Finally, we present data indicating that VCP-KMT, calmodulin-lysine methyltransferase and eight uncharacterized proteins together constitute a novel human protein methyltransferase family. The present work provides new insights on protein methylation and its links to human disease.Entities:
Mesh:
Substances:
Year: 2012 PMID: 22948820 DOI: 10.1038/ncomms2041
Source DB: PubMed Journal: Nat Commun ISSN: 2041-1723 Impact factor: 14.919